Michigan Medicine Adopts Higher Oxytocin Dose Protocol

A new protocol at Von Voigtlander Women's Hospital significantly reduces postpartum hemorrhage risks for vaginal births.

Updated on Oct. 26, 2026 in Women’s Health

A close-up of a stainless steel medical IV stand and plastic tubing in a sterile hospital room. — University of Michigan Health researchers found that doubling oxytocin doses during the hour after delivery reduced postpartum hemorrhage by 40% in vaginal births. AI Illustration. Upload story photo >

Live Poll

Do you trust that hospitals prioritize updated medical protocols to improve patient outcomes?

A clinical review of 2,674 births at University of Michigan Health Von Voigtlander Women's Hospital found that doubling the oxytocin dose in the hour after delivery reduced postpartum hemorrhage by approximately 40% for vaginal births. The study period concluded on July 6, 2024.

Why it matters

Postpartum hemorrhage remains a leading cause of maternal illness and death. This initiative sought to determine if higher-dose oxytocin protocols could effectively lower the rate of these severe obstetric complications.

The study analyzed 2,674 births, comparing the effect of increasing oxytocin dosages from 30 units to 60 units during the first hour postpartum. While vaginal births saw a 40% reduction in hemorrhage, cesarean births showed no significant change.

The players

Michigan Medicine

This is the academic medical center associated with the University of Michigan that includes the Von Voigtlander Women's Hospital.

University of Michigan Health Von Voigtlander Women's Hospital

This facility serves as a primary site for obstetric care and research within the Michigan Medicine health system.

The details

The implementation involved updating medication orders and infusion pump settings, alongside comprehensive staff training. Results indicated lower overall blood loss and a decreased reliance on additional medications for hemorrhage management.

The research comparison period began on January 1, 2024.
The data collection concluded on July 6, 2024.

Artificial Intelligence
Oct. 26
Ross School Hosts Inaugural AI Business Conference

Health Landscape

This study follows the established clinical standards set by the ACOG practice bulletin on postpartum hemorrhage prevention by testing higher dosage safety and efficacy. These findings update clinical practice benchmarks by providing specific data on the efficacy of increased oxytocin dosing.

Patients delivering at this facility may experience updated care protocols designed to reduce the risk of serious blood loss following vaginal birth. These changes aim to improve maternal safety outcomes without requiring different participation from the patient.

The takeaway

Clinicians are increasingly refining post-birth medication protocols to combat maternal health complications. Patients should discuss hospital-specific hemorrhage prevention strategies with their obstetric providers during prenatal visits.